107 results

• Statute of Limitations for Risperdal Breast Growth Lawsuits to be Considered by PA Supreme Court

  July 10, 2018

  Austin Kirk

  The Pennsylvania Supreme Court will hear an appeal that could determine when the statute of limitations for thousands of Risperdal breast growth lawsuits.

• Risperdal Punitive Damages May Be Awarded in Thousands of Cases Pending in Philadelphia: Court

  January 9, 2018

  Austin Kirk

  A ruling by a panel of Pennsylvania judges opens the way for about 6,000 plaintiffs with Risperdal lawsuits filed in that state to seek punitive damages from Johnson & Johnson over claims that the drug causes breast growth in boys.

• Risperdal Defense Verdict Reversed, Judges Call For New Trial On Causation, Damages

  November 27, 2017

  Irvin Jackson

  The Pennsylvania Superior Court has overturned Johnson & Johnson's only win before a jury in Risperdal litigation in that state, ordering a new trial.

• Risperdal Gynecomastia Lawsuit Results in $1M Verdict in NY Federal Court

  October 9, 2017

  Irvin Jackson

  A Risperdal lawsuit has resulted in a $1 million verdict for a 24-year-old man who began growing breasts after he started taking the drug when he was 9-years-old.

• More Than 5,500 Risperdal Gynecomastia Lawsuits Now Pending In Philadelphia Court

  July 14, 2017

  Austin Kirk

  New Risperdal lawsuits are being filed at a prodigious rate, with the number of cases more than doubling this year in Pennsylvania state court.

• Risperdal Trial Ends In Defense Ruling Over Lack of Evidence

  April 18, 2017

  Irvin Jackson

  As thousands of new cases are being filed over Risperdal gynecomastia claims, a trial in Philadelphia has ended in a summary judgment for the defense over a lack of evidence in that case.

• J&J Seeks Stricter Risperdal Lawsuit Filing Rules

  February 28, 2017

  Irvin Jackson

  The makers of Risperdal are calling for more stringent requirements for the filing of new gynecomastia lawsuits as the number of plaintiffs claiming the drug caused abnormal breast growth continues to increase.

• Risperdal, Abilify Risks May Outweigh Benefits Provided by Drugs, Safety Group Warns

  January 27, 2017

  Irvin Jackson

  Antipsychotics such as Abilify and Risperdal are so hard on the body that most patients do not complete treatment, according to the findings of a new study, which suggests that the risks of the drugs may outweigh their benefits.

• Youths With ADHD May Be Prescribed Unnecessary Antipsychotics: Study

  January 24, 2017

  Irvin Jackson

  A new study warns that many children with ADHD are being prescribed antipsychotics, like Risperdal, without having a diagnosis of other mental illnesses.

• Risperdal Lawsuits Continue to Mount as Gynecomastia Settlements Reached in Bellwether Cases

  January 20, 2017

  Irvin Jackson

  New cases continue to be filed on behalf of boys and young men diagnosed with gynecomastia from Risperdal, as the drug maker selectively settles individual lawsuits as trials are set to begin.